Senators question Allergan CEO on tribe patent deal

Por um escritor misterioso

Descrição

A group of five senators said the deal was a "blatant attempt to further Allergan's market monopoly" on its $1.5 billion eye drug, Restasis.
Senators question Allergan CEO on tribe patent deal
Senators question Allergan CEO on tribe patent deal
Senators question Allergan CEO on tribe patent deal
CONTROVERSIAL STRATEGY: SELLING PATENTS TO A NATIVE AMERICAN TRIBE
Senators question Allergan CEO on tribe patent deal
Allergan CEO Defends Mohawk Tribe Restasis Patent Deal
Senators question Allergan CEO on tribe patent deal
Allergan does patent deal for Restasis with Native American tribe
Senators question Allergan CEO on tribe patent deal
BLS Letter To Grassley Feinstein 10-3-17 FINAL, PDF, Intellectual Property
Senators question Allergan CEO on tribe patent deal
Allergan Mohawk Tribe Patent Deal
Senators question Allergan CEO on tribe patent deal
How a Native American tribe came to own one of the world's most valuable patents
Senators question Allergan CEO on tribe patent deal
Patent transfer to Mohawk tribe intended to stop generic drugs
Senators question Allergan CEO on tribe patent deal
Allergan deal with Mohawk tribe casts patent shadow
Senators question Allergan CEO on tribe patent deal
Senators blast Allergan's tribal deal, social contract as 'hypocrisy
Senators question Allergan CEO on tribe patent deal
Speaker Biographies and Faculty - Scope Summit
de por adulto (o preço varia de acordo com o tamanho do grupo)